40811 - NHS Protect: Staff (Answered)

Charlotte Leslie
To ask the Secretary of State for Health, how many people were employed by NHS Protect at each Civil Service pay grade in each year since 2010.

George Freeman

NHS Protect co-ordinates anti-crime work in the National Health Service in England. This not only includes investigations and prosecutions but also managing information and intelligence and, wherever possible, ensuring crime is deterred and prevented.


2010/11

2011/12

2012/13

40810 - NHS Protect (Answered)

Charlotte Leslie
To ask the Secretary of State for Health, how many prosecutions have been instigated by NHS Protect in each year since 2010.

George Freeman

NHS Protect co-ordinates anti-crime work in the National Health Service in England. This not only includes investigations and prosecutions but also managing information and intelligence and, wherever possible, ensuring crime is deterred and prevented.


2010/11

2011/12

2012/13

2013/14

40748 - Vaccination: Babies (Answered)

Mr Virendra Sharma
To ask the Secretary of State for Health, pursuant to the Answer of 22 January 2016 to Question 22462, if he will place in the Library a copy of NHS England's report on individual funding requests for palivizumab.

George Freeman

NHS England has advised that it is assessing the effect of individual funding requests for palivizumab on premature babies at risk of severe complications from respiratory syncytial virus. It will report its findings in July 2016.

40553 - NHS: Sustainable Development (Answered)

Caroline Lucas
To ask the Secretary of State for Health, pursuant to the Answer of 23 May 2016 to Question 37279, if he will make it his policy to ensure there is a formal public consultation on every Sustainability and Transformation Plan footprint.

George Freeman

40616 - NHS: Sustainable Development (Answered)

Justin Madders
To ask the Secretary of State for Health, what guidance (a) his Department and (b) NHS England have provided to Sustainability and Transformation footprint teams on involving university providers in the development of Sustainability and Transformation Plans.

George Freeman

40703 - NHS: Drugs (Answered)

Mr Jim Cunningham
To ask the Secretary of State for Health, pursuant to the Answer of 13 June 2016 to Question 40024, on NHS: drugs, what the most recent price paid per pack by the NHS was for each of the drugs listed in that Answer.

George Freeman

40702 - NHS: Contracts (Answered)

Mr Jim Cunningham
To ask the Secretary of State for Health, what the largest financial contracts between the NHS and private companies were in each of the last five years; and if he will make a statement.

George Freeman

The Department does not hold this information, as it is not collated centrally. It is for individual clinical commissioning groups (CCGs) to take decisions on which providers, including those from the private sector, are awarded contracts for the provision of NHS services for their respective regions.

40704 - NHS: Drugs (Answered)

Mr Jim Cunningham
To ask the Secretary of State for Health, pursuant to the Answer of 13 June 2016 to Question 40017, on NHS: drugs, what the value is of the five contracts listed in that Answer.

George Freeman

40368 - NHS: Logos (Answered)

Justin Madders
To ask the Secretary of State for Health, pursuant to the Answer of 9 June 2016 to Question 39429, on NHS logos, what the cost to his Department has been of legal advice on the use of the NHS logo by the Vote Leave Campaign; and what plans he has to apply for injunctive proceedings related to the use of that logo.

George Freeman

40282 - Nivolumab (Answered)

Mark Durkan
To ask the Secretary of State for Health, what assessment he has made of the effect of the time taken for NICE appraisal processes for the provision of Nivolumab on the treatment of NHS patients with non-small cell lung cancer; and if he will make a statement.

George Freeman

No such assessment has been made.

The National Institute for Health and Care Excellence (NICE) is currently carrying out technology appraisals of nivolumab for two lung cancer indications:

Pages